Table 3.
Immunological score and responder rate among assessable GX301 treated patients
| Immunological score* (n.) | Regimen 1 (n = 20) | Regimen 2 (n = 24) | Regimen 3 (n = 19) | All regimens (n = 63) |
|---|---|---|---|---|
| 0 | 0 | 0 | 3 | 3 (4.8%) |
| 1 | 4 | 3 | 4 | 11 (17.5%) |
| 2 | 3 | 8 | 4 | 15 (23.8%) |
| 3 | 12 | 11 | 4 | 27 (42.9%) |
| 4 | 1 | 1 | 4 | 6 (9.5%) |
| 5 | 0 | 1 | 0 | 1 (1.6%) |
| 6 | 0 | 0 | 0 | 0 |
| Immunological responders** (score ≥ 3), n. (%) | 13 (65) | 13 (54.2) | 8 (42.1) | 34 (54.0) |
*The immunological score was the sum of positive responses observed at the immunological tests performed on days 90 and 180 after vaccination
**As per protocol criteria, immunological responders were patients achieving an immunological score ≥ 3